| 10:00 |
Pharmacogenomics: Molecular Profiling of Solid Tumours
Dr. B.R Das, President of Research and Innovation, Mentor of Molecular Pathology and Clinical Research Services, Super Religare Laboratories Ltd. Mumbai, India |
| |
| 10:30 |
Genomics Classification and Risk-Stratification of Multiple Myeloma
Dr. Imran Mirza, Section Head, Molecular Diagnostics Laboratory, Pathology and Laboratory Medicine Institute, Sheikh Khalifa Medical City, Abu Dhabi, UAE |
| |
| 11:00 |
Molecular Diagnostics testing of human Papillomavirus update
Dr. Hisham Shams, Group Medical Director, Al Borg Medical Laboratories, Saudi Arabia |
| |
| 11:30 |
Coffee Break |
| |
| Session 2: Genetic Disorders |
|
| |
| |
| 12:00 |
Prenatal Cytogenetic Screening of Fetal Abnormalities
Dr. Renjini Nambiar, Cytogeneticist, SRL International, Dubai, UAE |
| |
| 12:30 |
Utility of Genomic Microarray as a Primary Genomic Screen for Clinically Significant Imbalances
Dr. Andrew J. Conrad, Chief Science Officer, LabCorp and National Reference Laboratory, UAE |
| |
| 13:00 |
Lunch Break |
| |
| Session 3: Infectious Disease |
|
| |
| 14:30 |
Role of Molecular Diagnostics in the changing paradigm of Hepatitis C treatments
Dr Waheed Uz Zaman Tariq, Consultant Microbiologist and Virologist, Tawam Hospital, Al Ain, UAE |
| |
| 15:00 |
Emerging and re-emerging infectious diseases: Molecular diagnostic approaches
Prof. P.K. Uppal, Former Managing Director, BIBCOL, Department of Biotechnology, Ministry of Science, Advisor, Punjab and Uttar Pradesh Government, India |
| |
| 15:30 |
Molecular Diagnostics and Active Screening for Health-Care Associated Infections
Dr. Saad Baher El Badawi, Laboratory Director, Dr. Erfan & Bagedo General Hospital, Jeddah, KSA
|
| |
| 16:00 |
MDR-TB: Hopes and Challenges
Dr. Ali Rabaan, M.Med Sci, PhD, Head of Molecular Microbiology Laboratory, Saudi Aramco Medical Services Organisation, Dhahran, Saudi Arabia |
| |
| 16:30 |
Close of Track D |
|